Statistical Measurement [Domain] Statistical Measurement [Domain] Amount paid Payments For Other Commitments Payments For Other Commitments Schedule of Available-For-Sale Investments by Type of Security Debt Securities, Available-for-Sale [Table Text Block] Award Timing Predetermined Award Timing Predetermined [Flag] Related Party Transaction [Axis] Related Party Transaction [Axis] Entity File Number Entity File Number Additional Paid in Capital Additional Paid-in Capital [Member] Claire Mazumdan [Member] Claire Mazumdan IPO IPO [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Recent Accounting Pronouncements and Accounting Pronouncements Issued and Not Adopted New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Financial Assets Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Options outstanding Share-Based Payment Arrangement [Member] Other comprehensive loss: Other Comprehensive Income (Loss), Tax [Abstract] Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Net Loss per share, basic (in usd per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Significant Agreements – Related Parties Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Common stock, capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance U.S. Treasury Bills US Treasury Bill Securities [Member] Stock, Class of Stock [Table] Stock, Class of Stock [Table] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Consolidation Consolidation, Policy [Policy Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Common Stock Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Research and Development Expense Research and Development Expense, Policy [Policy Text Block] Cash paid for tax Income Taxes Paid Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Total Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Number of securities held in unrealized loss position Debt Securities, Available-for-Sale, Number Of Securities In Unrealized Loss Position Debt Securities, Available-for-Sale, Number Of Securities In Unrealized Loss Position Issuance of common stock, and accompanying pre-funded warrants, net of offering cost (in shares) Stock Issued During Period, Shares, New Issues Current assets: Assets, Current [Abstract] Canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Vesting of early exercise stock options Vesting of Early Exercise Stock Options Vesting of Early Exercise Stock Options Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Cover [Abstract] Money market funds included within cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] Weighted-Average Exercise Price, Exercisable (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price General and administrative General and Administrative Expense [Member] Total, Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] 2026 Inducement Plan 2026 Inducement Plan [Member] 2026 Inducement Plan Retirement Benefits [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Net loss before income taxes Net income before losses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Security deposit Security Deposit Liability Name Measure Name Schedule of Stock-Based Compensation Expense Recognized in Statements of Operations Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liability – current portion Operating Lease, Liability, Current Class of Stock [Line Items] Class of Stock [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Award Type Award Type [Axis] Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol Income Tax Income Tax, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Lara Meisner [Member] Lara Meisner Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Master Clinical Contract Services Agreement Incremental Return Master Clinical Contract Services Agreement Incremental Return [Member] Master Clinical Contract Services Agreement Incremental Return Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Registration payment arrangement, maximum potential consideration Registration Payment Arrangement, Maximum Potential Consideration Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Related Party Related Party [Member] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Proceeds from maturities and sales of marketable securities Proceeds from Sale, Maturity and Collection of Investments Interest income Interest income Investment Income, Interest Accrued research and development expenses Accrued Research And Development Expense, Current Accrued Research And Development Expense, Current Option shares issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other assets Prepaid Expense and Other Assets, Current Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income tax expense Income Tax Expense (Benefit) 12 Months or Longer, Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Sale of Stock [Domain] Sale of Stock [Domain] Master Clinical Contract Services Agreement Master Clinical Contract Services Agreement [Member] Master Clinical Contract Services Agreement Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Weighted- Average Exercise Price, Exercisable and expected to vest (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Subsidiary or Equity Method Investee, Sale of Stock [Table] Subsidiary or Equity Method Investee, Sale of Stock [Table] Organization, Consolidation and Presentation of Financial Statements [Abstract] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from exercise of options Proceeds from Stock Options Exercised City Area Code City Area Code David Raben [Member] David Raben Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Marketable Securities Investment [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses and other current liabilities Total Accrued Liabilities, Current Commitments and Contingencies Disclosure [Abstract] Investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative Total general and administrative expenses General and Administrative Expense Unrecognized compensation costs Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Unvested stock options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Related Party Transactions [Abstract] Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation Depreciation Money market funds included within cash and cash equivalents Money Market Funds [Member] Offering costs included in accounts payable and accrued expenses Offering Costs Incurred During Noncash or Partial Noncash Transaction Offering Costs Incurred During Noncash or Partial Noncash Transaction Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Percentage of increase in future issuance reserved share Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Share Authorization Increase, Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Share Authorization Increase, Percentage Description of Business, Organization, and Liquidity Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and investments Investments and Cash Number of reportable segments Number of Reportable Segments Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province IQVIA RDS Inc IQVIA RDS Inc [Member] IQVIA RDS Inc Marketable Securities Marketable Securities, Policy [Policy Text Block] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Syngene Agreements Syngene Agreements [Member] Syngene Agreements Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Total current liabilities Total current liabilities Liabilities, Current Over-Allotment Option Over-Allotment Option [Member] Investment Categorization Axis [Domain] Investment Categorization Axis [Domain] Investment Categorization Axis [Domain] Individual: Individual [Axis] Defined contribution, plan cost Defined Contribution Plan, Cost Research and development Research and Development Expense [Member] Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right of use asset – operating lease Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Master Clinical Services Agreement, Investigator Grant Payment Master Clinical Services Agreement, Investigator Grant Payment [Member] Master Clinical Services Agreement, Investigator Grant Payment Unrecognized share-based compensation cost, period of recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Issuance of common stock upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Equity [Abstract] Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Weighted Average Assumptions Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Segment Reporting Segment Reporting Disclosure [Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Fair value of common stock (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions During Period, Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions During Period, Exercise Price Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Other assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Sale of stock, commission fee percentage Sale Of Stock, Commission Fee, Percentage Sale Of Stock, Commission Fee, Percentage Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Axis] Class of warrant or right, exercise price of warrants or rights (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Master Clinical Contract Services Agreement Deposit For Pass Through Costs Master Clinical Contract Services Agreement Deposit For Pass Through Costs [Member] Master Clinical Contract Services Agreement Deposit For Pass Through Costs Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Nonrelated Party Nonrelated Party [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Other Commitments [Axis] Other Commitments [Axis] Master Clinical Contract Services Agreement, Refundable Deposit Master Clinical Contract Services Agreement, Refundable Deposit [Member] Master Clinical Contract Services Agreement, Refundable Deposit Fair Value Measurements Fair Value Disclosures [Text Block] Stockholders' equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Total research and development Research and Development Expense Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Operating lease liability – net of current portion Operating Lease, Liability, Noncurrent Difference in offering price from common stock (in usd per share) Class of Warrant or Right, Common Stock, Exercise Price of Warrants or Rights, Difference Class of Warrant or Right, Common Stock, Exercise Price of Warrants or Rights, Difference Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Shares, Exercisable and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Less than 12 Months, Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Total Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Number of operating segments Number of Operating Segments Net amortization of premiums and discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted Average – Remaining Contractual Life (years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Master Clinical Contract Services Agreement Deposits For Services Master Clinical Contract Services Agreement Deposits For Services [Member] Master Clinical Contract Services Agreement Deposits For Services Warrants Warrants, Policy [Policy Text Block] Warrants, Policy Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Sale of Stock [Axis] Sale of Stock [Axis] Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name All Award Types Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Initial payment amount Other Commitment Employee Stock Employee Stock [Member] Significant Agreements Commitments Disclosure [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Financial Instruments [Domain] Financial Instruments [Domain] Unrealized loss on marketable securities, net of tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Segments [Domain] Segments [Domain] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Minimum Minimum [Member] Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Net Loss Per Common Share Earnings Per Share, Policy [Policy Text Block] Company Selected Measure Name Company Selected Measure Name Manufacturing and process development Clinical Operations And Development Expense Clinical Operations And Development Expense Income tax expense Income Tax Expense (Benefit), Including Adjustments Income Tax Expense (Benefit), Including Adjustments Preferred stock $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value, 500,000,000 and 500,000,000 shares authorized; 65,547,037 and 56,600,724 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Ryan Cohlhepp [Member] Ryan Cohlhepp Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Master Services Agreement Master Services Agreement [Member] Master Services Agreement Weighted-average number common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Other commitment, liability, refundable deposit, amount Other Commitment, Liability, Refundable Deposit, Amount Other Commitment, Liability, Refundable Deposit, Amount Segment Reporting Segment Reporting, Policy [Policy Text Block] Commitments and Contingencies (Note 7) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date Total marketable securities with original maturity of one to two years Investments With Maturity Of One To Two Years [Member] Investments With Maturity Of One To Two Years PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Area of land (in square feet) Lessee, Operating Lease, Area Lessee, Operating Lease, Area Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Income Taxes Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Facility costs, IT, office expense and other Facility, IT, Office And Other Expense Facility, IT, Office And Other Expense Weighted Average – Remaining Contractual Life (years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease liabilities Increase (Decrease) in Operating Lease Liability Defined Contribution Plan Defined Contribution Plan [Text Block] Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Proceeds from issuance on common stock and accompanying pre-funded warrants, net of issuance costs Proceeds from Issuance of Common Stock All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Expiration period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] 2024 Stock Option And Grant Plan 2024 Stock Option and Grant Plan [Member] 2024 Stock Option and Grant Plan Percent of outstanding shares Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Aggregate intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable securities Marketable Securities, Current Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Total other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Stock Options Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Total operating expenses Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Related Party Transaction [Table] Related Party Transaction [Table] Net Loss per share, diluted (in usd per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table] Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table] Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Research and development personnel cost and other (including stock-based compensation) Research And Development Personnel Cost, Including Share-Based Payment Arrangement Expense Research And Development Personnel Cost, Including Share-Based Payment Arrangement Expense Total other income Total other income Nonoperating Income (Expense) ATM Program ATM Program [Member] ATM Program Investments, Debt and Equity Securities [Abstract] Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items] Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Exercised (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued bonus and payroll related expenses Employee-related Liabilities, Current Accrued manufacturing expenses Accrued Manufacturing Expenses, Current Accrued Manufacturing Expenses, Current Research Other Research and Development Expense Incentive Stock Options And Non-Qualified Stock Options Incentive Stock Options And Non-Qualified Stock Options [Member] Incentive Stock Options And Non-Qualified Stock Options Stockholder's Equity Equity [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Subsidiary or Equity Method Investee [Line Items] Subsidiary or Equity Method Investee [Line Items] Schedule of Available-For-Sale Securities in an Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Expiration Date Trading Arrangement Expiration Date Other Commitments [Domain] Other Commitments [Domain] Accrued other Other Accrued Liabilities, Current Vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Unrealized loss on marketable securities, net of tax Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Expected dividend rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend Adoption Date Trading Arrangement Adoption Date Weighted Average – Remaining Contractual Life (years), Exercisable and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Lease, term of contract Lessee, Operating Lease, Term of Contract General and Administrative Expense Selling, General and Administrative Expenses, Policy [Policy Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating loss Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Ivan Hyep [Member] Ivan Hyep Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] 12 Months or Longer, Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Less than 12 Months, Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Total marketable securities with original maturity of one year or less Investments With Maturity Of One Year Or Less [Member] Investments With Maturity Of One Year Or Less Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Payables and Accruals [Abstract] Professional fees Professional Fees Reportable Segment Reportable Segment [Member] Reportable Segment Statement [Table] Statement [Table] Adjustments to reconcile net loss to cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted-average fair value of options granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Total, Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Options outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Public offering price (in usd per share) Sale of Stock, Price Per Share Master Clinical Contract Services Agreement, Additional Refundable Deposit Master Clinical Contract Services Agreement, Additional Refundable Deposit [Member] Master Clinical Contract Services Agreement, Additional Refundable Deposit Shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Number of additional shares allowable under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Allowable Under The Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Allowable Under The Plan Weighted-average number common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic General and administrative personnel costs (including stock-based compensation) General And Administrative Personnel Costs Including Stock-based Compensation General And Administrative Personnel Costs Including Stock-based Compensation Related Party Transaction [Domain] Related Party Transaction [Domain] Shares, Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Lease, base rent Operating Lease, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Other income Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Investment Categorization Axis [Axis] Investment Categorization Axis [Axis] Investment Categorization Axis Beginning balance (in usd per share) Ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Other commitment percentage Other Commitment Percentage Other Commitment Percentage Common stock, shares issued (in shares) Common Stock, Shares, Issued Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Trading Arrangement: Trading Arrangement [Axis] Clinical operations and development Manufacturing And Process Development Expense Manufacturing And Process Development Expense Total Shareholder Return Amount Total Shareholder Return Amount Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Canceled (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price February 2026 Offering February 2026 Offering [Member] February 2026 Offering BBL Agreements BBL Agreements [Member] BBL Agreements Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Proceeds from issuance on common stock and accompanying pre-funded warrants, net of issuance costs Proceeds from Issuance Initial Public Offering Operating expenses Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Issuance of common stock, and accompanying pre-funded warrants, net of issuance cost Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Common Equity Common Stock [Member] Fair Value Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net (decrease)/increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Accrued professional fees Accrued Professional Fees, Current